Zura Bio Future Growth
Future criteria checks 0/6
Zura Bio's earnings are forecast to decline at 31.5% per annum while its annual revenue is expected to grow at 68.9% per year. EPS is expected to decline by 20.4% per annum.
Key information
-31.5%
Earnings growth rate
-20.4%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | 68.9% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 19 Sep 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4 | -80 | -70 | -87 | 7 |
| 12/31/2025 | N/A | -59 | -46 | -58 | 7 |
| 12/31/2024 | N/A | -37 | -24 | -32 | 7 |
| 6/30/2024 | N/A | -28 | -25 | -18 | N/A |
| 3/31/2024 | N/A | -60 | -30 | -17 | N/A |
| 12/31/2023 | N/A | -69 | -23 | -15 | N/A |
| 9/30/2023 | N/A | -88 | -27 | -11 | N/A |
| 6/30/2023 | N/A | -81 | -23 | -9 | N/A |
| 3/31/2023 | N/A | -41 | -15 | -4 | N/A |
| 12/31/2022 | N/A | -35 | -14 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZURA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ZURA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ZURA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ZURA is forecast to have no revenue next year.
High Growth Revenue: ZURA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ZURA's Return on Equity is forecast to be high in 3 years time